<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37166076</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>01</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1537-6613</ISSN><JournalIssue CitedMedium="Internet"><Volume>228</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>Aug</Month><Day>31</Day></PubDate></JournalIssue><Title>The Journal of infectious diseases</Title><ISOAbbreviation>J Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Reduced Exercise Capacity, Chronotropic Incompetence, and Early Systemic Inflammation in Cardiopulmonary Phenotype Long Coronavirus Disease 2019.</ArticleTitle><Pagination><StartPage>542</StartPage><EndPage>554</EndPage><MedlinePgn>542-554</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/infdis/jiad131</ELocationID><Abstract><AbstractText Label="BACKGROUND">Mechanisms underlying persistent cardiopulmonary symptoms after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (postacute sequelae of coronavirus disease 2019 [COVID-19; PASC] or "long COVID") remain unclear. This study sought to elucidate mechanisms of cardiopulmonary symptoms and reduced exercise capacity.</AbstractText><AbstractText Label="METHODS">We conducted cardiopulmonary exercise testing (CPET), cardiac magnetic resonance imaging (CMR) and ambulatory rhythm monitoring among adults &gt;1 year after SARS-CoV-2 infection, compared those with and those without symptoms, and correlated findings with previously measured biomarkers.</AbstractText><AbstractText Label="RESULTS">Sixty participants (median age, 53 years; 42% female; 87% nonhospitalized; median 17.6 months after infection) were studied. At CPET, 18/37 (49%) with symptoms had reduced exercise capacity (&lt;85% predicted), compared with 3/19 (16%) without symptoms (P = .02). The adjusted peak oxygen consumption (VO2) was 5.2 mL/kg/min lower (95% confidence interval, 2.1-8.3; P = .001) or 16.9% lower percent predicted (4.3%-29.6%; P = .02) among those with symptoms. Chronotropic incompetence was common. Inflammatory markers and antibody levels early in PASC were negatively correlated with peak VO2. Late-gadolinium enhancement on CMR and arrhythmias were absent.</AbstractText><AbstractText Label="CONCLUSIONS">Cardiopulmonary symptoms &gt;1 year after COVID-19 were associated with reduced exercise capacity, which was associated with earlier inflammatory markers. Chronotropic incompetence may explain exercise intolerance among some with "long COVID."</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Durstenfeld</LastName><ForeName>Matthew S</ForeName><Initials>MS</Initials><Identifier Source="ORCID">0000-0002-7612-3352</Identifier><AffiliationInfo><Affiliation>Department of Medicine, University of California, San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiology, Zuckerberg San Francisco General, University of California, San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peluso</LastName><ForeName>Michael J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of California, San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of HIV, Infectious Diseases, and Global Medicine, Zuckerberg San Francisco General Hospital, University of California, San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaveti</LastName><ForeName>Punita</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of California, San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiology, UCSF Health, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hill</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>School of Medicine, University of California, San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Danny</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Zuckerberg San Francisco General, University of California, San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sander</LastName><ForeName>Erica</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Division of Cardiology, UCSF Health, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Swaminathan</LastName><ForeName>Shreya</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Zuckerberg San Francisco General, University of California, San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arechiga</LastName><ForeName>Victor M</ForeName><Initials>VM</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Zuckerberg San Francisco General, University of California, San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Scott</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of HIV, Infectious Diseases, and Global Medicine, Zuckerberg San Francisco General Hospital, University of California, San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goldberg</LastName><ForeName>Sarah A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>School of Medicine, University of California, San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoh</LastName><ForeName>Rebecca</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Zuckerberg San Francisco General, University of California, San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chenna</LastName><ForeName>Ahmed</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Monogram Biosciences, LabCorp, University of California, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yee</LastName><ForeName>Brandon C</ForeName><Initials>BC</Initials><AffiliationInfo><Affiliation>Monogram Biosciences, LabCorp, University of California, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Winslow</LastName><ForeName>John W</ForeName><Initials>JW</Initials><AffiliationInfo><Affiliation>Monogram Biosciences, LabCorp, University of California, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petropoulos</LastName><ForeName>Christos J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Monogram Biosciences, LabCorp, University of California, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kelly</LastName><ForeName>J Daniel</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Institute of Global Health Sciences, University of California, San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>F.I. Proctor Foundation, University of California, San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Experimental Medicine, University of California, San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Glidden</LastName><ForeName>David V</ForeName><Initials>DV</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Henrich</LastName><ForeName>Timothy J</ForeName><Initials>TJ</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of California, San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Experimental Medicine, University of California, San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martin</LastName><ForeName>Jeffrey N</ForeName><Initials>JN</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Yoo Jin</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>Cardiac and Pulmonary Imaging, Department of Radiology, University of California, San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aras</LastName><ForeName>Mandar A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of California, San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiology, UCSF Health, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Long</LastName><ForeName>Carlin S</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of California, San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiology, UCSF Health, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grandis</LastName><ForeName>Donald J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of California, San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiology, UCSF Health, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deeks</LastName><ForeName>Steven G</ForeName><Initials>SG</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of California, San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of HIV, Infectious Diseases, and Global Medicine, Zuckerberg San Francisco General Hospital, University of California, San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hsue</LastName><ForeName>Priscilla Y</ForeName><Initials>PY</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of California, San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiology, Zuckerberg San Francisco General, University of California, San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K12 HL143961</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K24 AI112393</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AI027763</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>L30 HL159695</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>L30 AI147159</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K23 AI157875</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001872</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>L30 AI126521</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K23 AI146268</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Infect Dis</MedlineTA><NlmUniqueID>0413675</NlmUniqueID><ISSNLinking>0022-1899</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D003287">Contrast Media</NameOfSubstance></Chemical><Chemical><RegistryNumber>AU0V1LM3JT</RegistryNumber><NameOfSubstance UI="D005682">Gadolinium</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="UpdateOf"><RefSource>medRxiv. 2023 Mar 21:2022.05.17.22275235. doi: 10.1101/2022.05.17.22275235</RefSource><PMID Version="1">35677073</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017079" MajorTopicYN="Y">Exercise Tolerance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003287" MajorTopicYN="N">Contrast Media</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006339" MajorTopicYN="N">Heart Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005682" MajorTopicYN="N">Gadolinium</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">cardiac magnetic resonance imaging</Keyword><Keyword MajorTopicYN="N">cardiopulmonary exercise testing</Keyword><Keyword MajorTopicYN="N">chronotropic incompetence</Keyword><Keyword MajorTopicYN="N">postacute sequelae of COVID-19</Keyword></KeywordList><CoiStatement>Potential conflicts of interest. A. C., B. C. Y., J. W. W., and C. J. P. are employees of Monogram Biosciences, a division of LabCorp. They performed biomarker measurements blinded to participant data. P. Y. H. has received modest honoraria from Gilead and Merck and a research grant from Novartis, unrelated to the submitted work. All other authors report no potential conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>1</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>11</Day><Hour>13</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>11</Day><Hour>7</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>5</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37166076</ArticleId><ArticleId IdType="pmc">PMC10686699</ArticleId><ArticleId IdType="doi">10.1093/infdis/jiad131</ArticleId><ArticleId IdType="pii">7159960</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ballering &#xa0;AV, van Zon &#xa0;SKR, Olde Hartman &#xa0;TC, Rosmalen &#xa0;JGM; Lifelines Corona Research Initiative. &#xa0;Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. Lancet &#xa0;2022; 400:452&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9352274</ArticleId><ArticleId IdType="pubmed">35934007</ArticleId></ArticleIdList></Reference><Reference><Citation>Durstenfeld &#xa0;MS, Peluso &#xa0;MJ, Kelly &#xa0;JD, et al. &#xa0;Role of antibodies, inflammatory markers, and echocardiographic findings in postacute cardiopulmonary symptoms after SARS-CoV-2 infection. JCI Insight &#xa0;2022; 7:e157053.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9220849</ArticleId><ArticleId IdType="pubmed">35389890</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann &#xa0;VO, Carerj &#xa0;ML, Wieters &#xa0;I, et al. &#xa0;Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol &#xa0;2020; 5:1265&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Joy &#xa0;G, Artico &#xa0;J, Kurdi &#xa0;H, et al. &#xa0;Prospective case-control study of cardiovascular abnormalities 6 months following mild COVID-19 in healthcare workers. JACC Cardiovasc Imaging &#xa0;2021; 14:2155&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8105493</ArticleId><ArticleId IdType="pubmed">33975819</ArticleId></ArticleIdList></Reference><Reference><Citation>Cassar &#xa0;MP, Tunnicliffe &#xa0;EM, Petousi &#xa0;N, et al. &#xa0;Symptom persistence despite improvement in cardiopulmonary health&#x2014;insights from longitudinal CMR, CPET and lung function testing post-COVID-19. EClinicalMedicine &#xa0;2021; 41:101159.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8527025</ArticleId><ArticleId IdType="pubmed">34693230</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotecha &#xa0;T, Knight &#xa0;DS, Razvi &#xa0;Y, et al. &#xa0;Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonance. Eur Heart J &#xa0;2021; 42:1866&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7928984</ArticleId><ArticleId IdType="pubmed">33596594</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann &#xa0;VO, Martin &#xa0;S, Shchendrygina &#xa0;A, et al. &#xa0;Long-term cardiac pathology in individuals with mild initial COVID-19 illness. Nat Med &#xa0;2022; 28:2117&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9556300</ArticleId><ArticleId IdType="pubmed">36064600</ArticleId></ArticleIdList></Reference><Reference><Citation>Durstenfeld &#xa0;MS, Sun &#xa0;K, Tahir &#xa0;P, et al. &#xa0;Use of cardiopulmonary exercise testing to evaluate long COVID-19 symptoms in adults: a systematic review and meta-analysis. JAMA Netw Open &#xa0;2022; 5:e2236057.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9557896</ArticleId><ArticleId IdType="pubmed">36223120</ArticleId></ArticleIdList></Reference><Reference><Citation>Brubaker &#xa0;PH, Kitzman &#xa0;DW. Chronotropic incompetence: causes, consequences, and management. Circulation &#xa0;2011; 123:1010&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3065291</ArticleId><ArticleId IdType="pubmed">21382903</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso &#xa0;MJ, Kelly &#xa0;JD, Lu &#xa0;S, et al. &#xa0;Persistence, magnitude, and patterns of postacute symptoms and quality of life following onset of SARS-CoV-2 infection: cohort description and approaches for measurement. Open Forum Infect Dis &#xa0;2022; 9:ofab640.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8755302</ArticleId><ArticleId IdType="pubmed">35106317</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano &#xa0;JB, Murthy &#xa0;S, Marshall &#xa0;JC, Relan &#xa0;P, Diaz &#xa0;JV. A clinical case definition of post COVID-19 condition by a Delphi consensus. Lancet Infect Dis &#xa0;2021; 22:e102&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso &#xa0;MJ, Lu &#xa0;S, Tang &#xa0;AF, et al. &#xa0;Markers of immune activation and inflammation in individuals with postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection. J Infect Dis &#xa0;2021; 224:1839&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8643408</ArticleId><ArticleId IdType="pubmed">34677601</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso &#xa0;MJ, Deveau &#xa0;TM, Munter &#xa0;SE, et al. &#xa0;Chronic viral coinfections differentially affect the likelihood of developing long COVID. J Clin Invest &#xa0;2023; 133:e163669.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9888380</ArticleId><ArticleId IdType="pubmed">36454631</ArticleId></ArticleIdList></Reference><Reference><Citation>American Thoracic Society , American College of Chest Physicians. ATS/ACCP statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med &#xa0;2003; 167:211&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pubmed">12524257</ArticleId></ArticleIdList></Reference><Reference><Citation>Jimeno-Almazan &#xa0;A, Pallares &#xa0;JG, Buendia-Romero &#xa0;A, Martinez-Cava &#xa0;A, Courel-Ibanez &#xa0;J. Chronotropic incompetence in non-hospitalized patients with post-COVID-19 syndrome. J Clin Med &#xa0;2021; 10:5434.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8617992</ArticleId><ArticleId IdType="pubmed">34830716</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdallah &#xa0;SJ, Voduc &#xa0;N, Corrales-Medina &#xa0;VF, et al. &#xa0;Symptoms, pulmonary function, and functional capacity four months after COVID-19. Ann Am Thorac Soc &#xa0;2021; 18:1912&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8641826</ArticleId><ArticleId IdType="pubmed">33872135</ArticleId></ArticleIdList></Reference><Reference><Citation>Szekely &#xa0;Y, Lichter &#xa0;Y, Sadon &#xa0;S, et al. &#xa0;Cardiorespiratory abnormalities in patients recovering from coronavirus disease 2019. J Am Soc Echocardiogr &#xa0;2021; 34:1273&#x2013;84.e9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8425293</ArticleId><ArticleId IdType="pubmed">34508837</ArticleId></ArticleIdList></Reference><Reference><Citation>Margalit &#xa0;I, Yelin &#xa0;D, Sagi &#xa0;M, et al. &#xa0;Risk factors and multidimensional assessment of long coronavirus disease fatigue: a nested case-control study. Clin Infect Dis &#xa0;2022; 75:1688&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9383780</ArticleId><ArticleId IdType="pubmed">35403679</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladlow &#xa0;P, O'Sullivan &#xa0;O, Houston &#xa0;A, et al. &#xa0;Dysautonomia following COVID-19 is not associated with subjective limitations or symptoms but is associated with objective functional limitations. Heart Rhythm &#xa0;2022; 19:613&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8656177</ArticleId><ArticleId IdType="pubmed">34896622</ArticleId></ArticleIdList></Reference><Reference><Citation>Harding &#xa0;JL, Oviedo &#xa0;SA, Ali &#xa0;MK, et al. &#xa0;The bidirectional association between diabetes and long-COVID-19&#x2014;a systematic review. Diabetes Res Clin Pract &#xa0;2023; 195:110202.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9727969</ArticleId><ArticleId IdType="pubmed">36496030</ArticleId></ArticleIdList></Reference><Reference><Citation>

Hill &#xa0;E, Mehta &#xa0;H, Sharma &#xa0;S, et al.  &#xa0;Risk factors associated with post-acute sequelae of SARS-CoV-2 in an EHR cohort: a National COVID Cohort Collaborative (N3C) analysis as part of the NIH RECOVER program. medRxiv [Preprint: not peer reviewed]. 17 July 2022. Available from: https://www.medrxiv.org/content/10.1101/2022.08.15.22278603v1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.08.15.22278603v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Jouven &#xa0;X, Empana &#xa0;JP, Schwartz &#xa0;PJ, Desnos &#xa0;M, Courbon &#xa0;D, Ducimetiere &#xa0;P. Heart-rate profile during exercise as a predictor of sudden death. N Engl J Med &#xa0;2005; 352:1951&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">15888695</ArticleId></ArticleIdList></Reference><Reference><Citation>Savonen &#xa0;KP, Lakka &#xa0;TA, Laukkanen &#xa0;JA, et al. &#xa0;Heart rate response during exercise test and cardiovascular mortality in middle-aged men. Eur Heart J &#xa0;2006; 27:582&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">16399774</ArticleId></ArticleIdList></Reference><Reference><Citation>Lauer &#xa0;MS, Francis &#xa0;GS, Okin &#xa0;PM, Pashkow &#xa0;FJ, Snader &#xa0;CE, Marwick &#xa0;TH. Impaired chronotropic response to exercise stress testing as a predictor of mortality. JAMA &#xa0;1999; 281:524&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">10022108</ArticleId></ArticleIdList></Reference><Reference><Citation>Gulati &#xa0;M, Shaw &#xa0;LJ, Thisted &#xa0;RA, Black &#xa0;HR, Bairey Merz &#xa0;CN, Arnsdorf &#xa0;MF. Heart rate response to exercise stress testing in asymptomatic women: the St. James women take heart project. Circulation &#xa0;2010; 122:130&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">20585008</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh &#xa0;I, Joseph &#xa0;P, Heerdt &#xa0;PM, et al. &#xa0;Persistent exertional intolerance after COVID-19: insights from invasive cardiopulmonary exercise testing. Chest &#xa0;2022; 161:54&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8354807</ArticleId><ArticleId IdType="pubmed">34389297</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancini &#xa0;DM, Brunjes &#xa0;DL, Lala &#xa0;A, Trivieri &#xa0;MG, Contreras &#xa0;JP, Natelson &#xa0;BH. Use of cardiopulmonary stress testing for patients with unexplained dyspnea post-coronavirus disease. JACC Heart Fail &#xa0;2021; 9:927&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8629098</ArticleId><ArticleId IdType="pubmed">34857177</ArticleId></ArticleIdList></Reference><Reference><Citation>Ribeiro Baptista &#xa0;B, d'Humieres &#xa0;T, Schlemmer &#xa0;F, et al. &#xa0;Identification of factors impairing exercise capacity after severe COVID-19 pulmonary infection: a 3-month follow-up of prospective COVulnerability cohort. Respir Res &#xa0;2022; 23:68.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8938727</ArticleId><ArticleId IdType="pubmed">35317815</ArticleId></ArticleIdList></Reference><Reference><Citation>Hajiasgharzadeh &#xa0;K, Mirnajafi-Zadeh &#xa0;J, Mani &#xa0;AR. Interleukin-6 impairs chronotropic responsiveness to cholinergic stimulation and decreases heart rate variability in mice. Eur J Pharmacol &#xa0;2011; 673:70&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">22044916</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee &#xa0;J, Lee &#xa0;S, Zhang &#xa0;H, Hill &#xa0;MA, Zhang &#xa0;C, Park &#xa0;Y. Interaction of IL-6 and TNF-alpha contributes to endothelial dysfunction in type 2 diabetic mouse hearts. PLoS One &#xa0;2017; 12:e0187189.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5667841</ArticleId><ArticleId IdType="pubmed">29095915</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawasaki &#xa0;T, Kaimoto &#xa0;S, Sakatani &#xa0;T, et al. &#xa0;Chronotropic incompetence and autonomic dysfunction in patients without structural heart disease. Europace &#xa0;2010; 12:561&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">20097685</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang &#xa0;PH, Leu &#xa0;HB, Chen &#xa0;JW, et al. &#xa0;Comparison of endothelial vasodilator function, inflammatory markers, and N-terminal pro-brain natriuretic peptide in patients with or without chronotropic incompetence to exercise test. Heart &#xa0;2006; 92:609&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1860951</ArticleId><ArticleId IdType="pubmed">16159987</ArticleId></ArticleIdList></Reference><Reference><Citation>Stute &#xa0;NL, Stickford &#xa0;JL, Province &#xa0;VM, Augenreich &#xa0;MA, Ratchford &#xa0;SM, Stickford &#xa0;ASL. COVID-19 is getting on our nerves: sympathetic neural activity and haemodynamics in young adults recovering from SARS-CoV-2. J Physiol &#xa0;2021; 599:4269&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8447023</ArticleId><ArticleId IdType="pubmed">34174086</ArticleId></ArticleIdList></Reference><Reference><Citation>Faria &#xa0;D, Moll-Bernardes &#xa0;RJ, Testa &#xa0;L, et al. &#xa0;Sympathetic neural overdrive, aortic stiffening, endothelial dysfunction, and impaired exercise capacity in severe COVID-19 survivors: a mid-term study of cardiovascular sequelae. Hypertension &#xa0;2023; 80:470&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9847692</ArticleId><ArticleId IdType="pubmed">36416143</ArticleId></ArticleIdList></Reference><Reference><Citation>Drakos &#xa0;S, Chatzantonis &#xa0;G, Bietenbeck &#xa0;M, et al. &#xa0;A cardiovascular magnetic resonance imaging-based pilot study to assess coronary microvascular disease in COVID-19 patients. Sci Rep &#xa0;2021; 11:15667.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8329060</ArticleId><ArticleId IdType="pubmed">34341436</ArticleId></ArticleIdList></Reference><Reference><Citation>Bechsgaard &#xa0;DF, Hove &#xa0;JD, Suhrs &#xa0;HE, et al. &#xa0;Women with coronary microvascular dysfunction and no obstructive coronary artery disease have reduced exercise capacity. Int J Cardiol &#xa0;2019; 293:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">31345648</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown &#xa0;JT, Saigal &#xa0;A, Karia &#xa0;N, et al. &#xa0;Ongoing exercise intolerance following COVID-19: a magnetic resonance-augmented cardiopulmonary exercise test study. J Am Heart Assoc &#xa0;2022; 11:e024207.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9238618</ArticleId><ArticleId IdType="pubmed">35470679</ArticleId></ArticleIdList></Reference><Reference><Citation>Jamal &#xa0;SM, Landers &#xa0;DB, Hollenberg &#xa0;SM, et al. &#xa0;Prospective evaluation of autonomic dysfunction in post-acute sequela of COVID-19. J Am Coll Cardiol &#xa0;2022; 79:2325&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8976261</ArticleId><ArticleId IdType="pubmed">35381331</ArticleId></ArticleIdList></Reference><Reference><Citation>Novak &#xa0;P, Mukerji &#xa0;SS, Alabsi &#xa0;HS, et al. &#xa0;Multisystem involvement in post-acute sequelae of coronavirus disease 19. Ann Neurol &#xa0;2022; 91:367&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9011495</ArticleId><ArticleId IdType="pubmed">34952975</ArticleId></ArticleIdList></Reference><Reference><Citation>Han &#xa0;Y, Zhu &#xa0;J, Yang &#xa0;L, et al. &#xa0;SARS-CoV-2 infection induces ferroptosis of sinoatrial node pacemaker cells. Circ Res &#xa0;2022; 130:963&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8963443</ArticleId><ArticleId IdType="pubmed">35255712</ArticleId></ArticleIdList></Reference><Reference><Citation>Gold &#xa0;JE, Okyay &#xa0;RA, Licht &#xa0;WE, Hurley &#xa0;DJ. Investigation of long COVID prevalence and its relationship to Epstein-Barr virus reactivation. Pathogens &#xa0;2021; 10:763.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8233978</ArticleId><ArticleId IdType="pubmed">34204243</ArticleId></ArticleIdList></Reference><Reference><Citation>Ingul &#xa0;CB, Grimsmo &#xa0;J, Mecinaj &#xa0;A, et al. &#xa0;Cardiac dysfunction and arrhythmias 3 months after hospitalization for COVID-19. J Am Heart Assoc &#xa0;2022; 11:e023473.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9238505</ArticleId><ArticleId IdType="pubmed">35048715</ArticleId></ArticleIdList></Reference><Reference><Citation>Dewland &#xa0;TA, Whitman &#xa0;IR, Win &#xa0;S, et al. &#xa0;Prospective arrhythmia surveillance after a COVID-19 diagnosis. Open Heart &#xa0;2022; 9:e001758.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8783964</ArticleId><ArticleId IdType="pubmed">35058344</ArticleId></ArticleIdList></Reference><Reference><Citation>Aranyo &#xa0;J, Bazan &#xa0;V, Llados &#xa0;G, et al. &#xa0;Inappropriate sinus tachycardia in post-COVID-19 syndrome. Sci Rep &#xa0;2022; 12:298.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8741896</ArticleId><ArticleId IdType="pubmed">34996973</ArticleId></ArticleIdList></Reference><Reference><Citation>Hastie &#xa0;CE, Lowe &#xa0;DJ, McAuley &#xa0;A, et al. &#xa0;Outcomes among confirmed cases and a matched comparison group in the long-COVID in Scotland study. Nat Commun &#xa0;2022; 13:5663.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9556711</ArticleId><ArticleId IdType="pubmed">36224173</ArticleId></ArticleIdList></Reference><Reference><Citation>Durstenfeld &#xa0;MS, Peluso &#xa0;MJ, Peyser &#xa0;ND, et al. &#xa0;Factors associated with long COVID symptoms in an online cohort study. Open Forum Infect Dis &#xa0;2023; 10:ofad047.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9945931</ArticleId><ArticleId IdType="pubmed">36846611</ArticleId></ArticleIdList></Reference><Reference><Citation>Keteyian &#xa0;SJ, Brawner &#xa0;CA, Schairer &#xa0;JR, et al. &#xa0;Effects of exercise training on chronotropic incompetence in patients with heart failure. Am Heart J &#xa0;1999; 138:233&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">10426833</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonilla &#xa0;H, Quach &#xa0;TC, Tiwari &#xa0;A, et al. &#xa0;Myalgic encephalomyelitis/chronic fatigue syndrome is common in post-acute sequelae of SARS-CoV-2 infection (PASC): results from a post-COVID-19 multidisciplinary clinic. Front Neurol &#xa0;2023; 14:1090747.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9998690</ArticleId><ArticleId IdType="pubmed">36908615</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker &#xa0;M, Sawant &#xa0;HB, Flannery &#xa0;T, et al. &#xa0;Effect of using a structured pacing protocol on post-exertional symptom exacerbation and health status in a longitudinal cohort with the post-COVID-19 syndrome. J Med Virol &#xa0;2023; 95:e28373.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9878088</ArticleId><ArticleId IdType="pubmed">36461167</ArticleId></ArticleIdList></Reference><Reference><Citation>Jimeno-Almazan &#xa0;A, Buendia-Romero &#xa0;A, Martinez-Cava &#xa0;A, et al. &#xa0;Effects of a concurrent training, respiratory muscle exercise, and self-management recommendations on recovery from post-COVID-19 conditions: the RECOVE trial. J Appl Physiol (1985) &#xa0;2023; 134:95&#x2013;104.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9829459</ArticleId><ArticleId IdType="pubmed">36476156</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>